150 related articles for article (PubMed ID: 17086419)
1. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Verit FF; Celik H; Yazgan P; Erel O; Geyikli I
Arch Gynecol Obstet; 2007 May; 275(5):353-9. PubMed ID: 17086419
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
5. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
7. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
9. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
10. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
11. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
12. Association of serum paraoxonase concentration with serum lipid levels and bone mineral density measurements in early postmenopausal women.
Yoldemir T; Yavuz DG
Climacteric; 2015 Jun; 18(3):405-10. PubMed ID: 25333316
[TBL] [Abstract][Full Text] [Related]
13. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368
[TBL] [Abstract][Full Text] [Related]
14. Assessment of paraoxonase activities in patients with knee osteoarthritis.
Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
[TBL] [Abstract][Full Text] [Related]
15. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
Ribom EL; Ljunggren O; Mallmin H
J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
[TBL] [Abstract][Full Text] [Related]
16. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
[TBL] [Abstract][Full Text] [Related]
18. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease.
Verit FF; Erel O; Celik N
Hum Reprod; 2008 Jan; 23(1):100-4. PubMed ID: 18000171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
